{"id":"W2180558964","doi":"10.1055/s-0037-1617033","title":"Factor Xa inhibitors","year":2009,"lang":"en","type":"article","venue":"Hämostaseologie","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Rivaroxaban; Apixaban; Medicine; Edoxaban; Drug; Pharmacodynamics; Fondaparinux; Anticoagulant; Pharmacology; Clinical trial; Pharmacokinetics; Knee replacement; Intensive care medicine; Internal medicine; Venous thromboembolism; Warfarin; Surgery; Arthroplasty; Thrombosis; Atrial fibrillation","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006698533,0.0008353207,0.0009182973,0.0008639235,0.0005287101,0.00157361,0.0008412985,0.001245234,0.07334545],"category_scores_gemma":[0.002205679,0.0001856474,0.0008214547,0.0007816699,0.0002720501,0.0006434127,0.0008139226,0.001593298,0.0505963],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005905083,"about_ca_system_score_gemma":0.001084488,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009199805,"about_ca_topic_score_gemma":0.0009772261,"domain_scores_codex":[0.9990251,0.000146524,0.00009464091,0.0001218288,0.00046023,0.000151657],"domain_scores_gemma":[0.999493,0.00008195778,0.0000731384,0.00005794912,0.0001873942,0.0001064764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006379755,0.0003962565,0.001140297,0.001538514,0.0001431928,0.001158259,0.00005555091,0.0001934296,0.005770071,0.007053097,0.2395184,0.7423949],"study_design_scores_gemma":[0.0001371379,0.0002168431,0.0007946031,0.000293107,0.00003843676,0.002564736,0.00001799026,0.00005434137,0.001758767,0.001089345,0.9930245,0.00001034789],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"review","genre_scores_codex":[0.01293639,0.4056014,0.0125484,0.01944152,0.01072968,0.0008980813,0.006117912,0.001965944,0.5297607],"genre_scores_gemma":[0.1315099,0.2862653,0.01956538,0.02785152,0.006931516,0.001119432,0.01319378,0.000355651,0.5132076],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.07334545,"threshold_uncertainty_score":0.245365,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1260128776701787,"score_gpt":0.3735269286596272,"score_spread":0.2475140509894485,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}